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Abstract: A new, versatile method for the synthesis of, so far un-
known, variously substituted 4-methylidenepyrazolidin-3-ones as
potential cytotoxic agents is described. Target compounds were
synthesized from the corresponding 4-diethoxyphosphorylpyrazoli-
din-3-ones which were used as Horner–Wadsworth–Emmons
reagents for the olefination of formaldehyde. 4-Phosphorylpyr-
azolidin-3-ones were, in turn, obtained starting from the sodium salt
of ethyl 2-diethoxyphosphoryl-3-hydroxy-2-propenoate, ethyl 2-
acyl-2-diethoxyphosphorylacetates, or 3-methoxy-2-diethoxyphos-
phorylacrylate and monosubstituted or 1,2-disubstituted hydra-
zines.
Key words: alkylation, antitumor agents, heterocycles, lactams,
Michael addition, olefination
Carbo- and heterocycles containing an exo-methylidene
moiety conjugated with a carbonyl group constitute a
large class of natural and synthetic compounds which dis-
play a broad spectrum of biological properties, ranging
from cytotoxic/anticancer, allergenic, anti-inflammatory,
and cardiovascular to antibacterial, antifungal, and phyto-
toxic activities. These classes of compounds include α-
methylidenecyclopentanones 1,1 and α-alkylidene-γ- and
δ-lactones 2 and 3 as well as α-alkylidene-γ- and δ-lac-
tams 4 and 5 (Figure 1)2 It is believed that the Michael ac-
ceptor functionality, which is present in all these
compounds, can effectively react with various bionucleo-
philes and therefore is crucial for their biological activi-
ties.3
Figure 1
In a search for new, biologically promising analogues we
have developed syntheses of several classes of α-alkyli-
dene-γ- and δ-lactones, as well as α-methylidene-γ-lac-
tams, by applying a Horner–Wadsworth–Emmons
approach to the construction of the exo-alkylidene
bond.2b,4 Many of the compounds obtained in our labora-
tory turned out to be highly potent against several cancer
cell lines as well as against nosocomial and community-
associated staphylococci (MRSA) which are resistant to
most or all available therapeutic classes of antimicrobial
drugs.5 Recently, we envisaged that introduction of an ad-
ditional heteroatom to the lactone or lactam ring might be
beneficial for biological activity. Consequently, a series
of 4-methylideneisoxazolidin-5-ones 6 (Figure 2) con-
taining an additional nitrogen atom in the lactone ring, has
been synthesized in our laboratory and, to our satisfaction,
certain isoxazolidinones 6 proved to be very potent
against HL-60, NALM-6, MCF-7, and MDA-MB-231
cancer cells.6 The most active compounds have been sub-
jected to extended biological studies which have shed
light on their mode of action at the molecular level.7
Figure 2
Encouraged by these results we decided to develop the
synthesis of, so far unknown, 4-methylidenepyrazolidin-
3-ones 7 which have an additional nitrogen atom in the
lactam ring. Although it is well established that α-alkyli-
dene-γ-lactams usually display lower cytotoxic activity
than α-alkylidene-γ-lactones,5a–c on the other hand, these
species are considered as particularly promising because
the γ-lactam moiety can help to mitigate the biological
toxicity often observed for γ-lactones.8 Therefore, synthe-
sis of α-methylidene-γ-lactams with potentially enhanced
cytotoxicity profile seemed an attractive goal. In this pa-
per we describe our preliminary results concerning a con-
venient and versatile Horner–Wadsworth–Emmons
approach to variously substituted 4-methylidenepyrazoli-
din-3-ones 7.
Synthesis of 2-aryl-1-methyl-4-methylidenepyrazolidin-
3-ones 14a–e substituted with various aryl groups in posi-
tion 2 was accomplished as shown in Scheme 1. 1-Aryl-4-
diethoxyphosphoryl-1H-pyrazol-5-ols 11a–e were pre-
pared by adapting the literature procedure described for
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the corresponding 4-dimethoxyphosphorylpyrazol-5-ols.9
The sodium salt of ethyl 2-diethoxyphosphoryl-3-hy-
droxy-2-propenoate 8 was treated with arylhydrazine hy-
drochlorides 9a–e followed by addition of potassium
carbonate (Table 1). This one-pot, two-step reaction obvi-
ously proceeds via an addition–elimination sequence to
give substitution products 10a–e followed by intramolec-
ular cyclization. Pyrazoles 11a–e obtained in this fashion
were next N-methylated with dimethyl sulfate to give 2-
aryl-1-methyl-4-diethoxyphosphorylpyrazol-3-ones 12a–
e in satisfactory yields (Table 1).10 Unfortunately, all at-
tempts to introduce various substituents into position 5 of
the pyrazolone ring, by executing Michael addition of
Grignard reagents to 12, failed. Therefore, we decided to
perform the reduction of the double bond in pyrazolones
12 to provide access to Horner–Wadsworth–Emmons re-
agents 13. Standard hydrogenation of 12a in the presence
of palladium or platinum catalysts gave only starting ma-
terial. However, application of L-Selectride as a reducing
agent furnished the expected pyrazolidinones 13a–e in
good yields (Table 1).11 Finally, reaction of 13a–e with
paraformaldehyde in the presence of sodium hydride gave
the targeted 4-methylidenepyrazolidin-3-ones 14a–e in
good to excellent yields (Table 1).12
To gain access to 5-substituted 2-aryl-1-methyl-4-methy-
lidenepyrazolidin-3-ones 19a–g we decided to prepare
substituted 1-aryl-4-diethoxyphosphoryl-1H-pyrazol-5-
ols 16a–g from various ethyl 2-acyl-2-diethoxyphosphor-
ylacetates 15a–g and arylhydrazine hydrochlorides by ap-
plying a modified literature procedure13 (Scheme 2,
Scheme 1  Reagents and conditions: (a) H2O, reflux, 10 min; (b) K2CO3 (1.1 equiv), H2O, reflux, 10 min; (c) Me2SO4 (1.2 equiv), DCE, 80 °C,
18 h; (d) L-Selectride (1.25 equiv), THF, –78 °C, 1 h, then r.t., 18 h; (e) (CH2O)n (5 equiv), NaH (1.2 equiv), THF, r.t., 2 h.
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Table 1  Preparation of 1-Aryl-4-diethoxyphosphoryl-1H-pyrazol-5-ols 11a–e, 2-Aryl-4-diethoxyphosphoryl-1-methyl-1,2-dihydro-3H-pyr-
azol-3-ones 12a–e, 2-Aryl-4-diethoxyphosphoryl-1-methylpyrazolidin-3-ones 13a–e, and 2-Aryl-1-methyl-4-methylidenepyrazolidin-3-ones 
14a–e
Entry Compd Ar Yield of 11 (%)a Yield of 12 (%)a Yield of 13 (%)a Yield of 14 (%)a
1 a Ph 79 54 86 91
2 b 2-MeC6H4 86 72 77 68
3 c 4-MeC6H4 87 67 82 68
4 d 4-ClC6H4 85 46 80 84
5 e 4-BrC6H4 81 63 79 61
a Yield of purified, isolated products based on 8, 11, 12, or 13, respectively.
Scheme 2 Reagents and conditions: (a) 1. H2NNHAr·HCl, H2O, reflux, 2 h; 2. K2CO3 (2 equiv), reflux, 2 h, then r.t., 18 h; (b) H2NNHPh,
AcOH (2 equiv), H2O, reflux, 3 h; (c) CF3SO3Me (2 equiv), DCE, 80 °C, 2 h; (d) L-Selectride (1.25 equiv), THF, –78 °C, 1 h, then r.t., 18 h;
(e) (CH2O)n (5 equiv), NaH (1.2 equiv), THF, r.t., 2 h.
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procedure a). This procedure worked well for alkyl-sub-
stituted acetates 15a–e (R = Alk) but aryl-substituted ace-
tates 15f,g (R = Ar) gave low yield of the expected
pyrazoles. Pleasingly, heating aryl-substituted acetates
15f,g and phenylhydrazine with acetic acid in water (pro-
cedure b) furnished 1,3-diarylpyrazolols 16f,g in good
yields (Table 2).14 N-Methylation of pyrazolols 16a–g10
using methyl triflate followed by reduction of 2-aryl-1-
methylpyrazol-3-ones 17a–g11 with L-Selectride gave
Horner–Wadsworth–Emmons reagents 18a–g, which
were obtained as single isomers or mixtures of trans and
cis diastereoisomers in the ratio shown in Table 2. Due to
highly basic conditions employed during the reduction
one could expect thermodynamic control within the reac-
tion and the preferential formation of the trans isomers.
Unfortunately, resonances for the H-4 and H-5 protons in
the 1H NMR spectra of pyrazolidiones 18 were not suffi-
ciently resolved to determine JH4–H5 coupling constants
and to confirm the assumed trans configuration of these
compounds. In view of the planned transformation of pyr-
azolidinones 18 into methylidenepyrazolidinones 19 no
efforts were undertaken to separate the diastereoisomers.
In the final step, pyrazolidinones 18a–g were used for the
olefination with formaldehyde to provide final 5-substi-
tuted pyrazolidinones 19a–g in good yields (Table 2).12
Having accomplished the synthesis of 3-methylidene-1-
methyl-2-arylpyrazolidin-3-ones 14a–e and 19a–g we
turned our attention to the reaction of the sodium salt of 3-
hydroxy-2-propenoate 8 with disubstituted hydrazines.
To our disappointment the reaction of 8 with 1,2-diphe-
nylhydrazine hydrochloride did not occur. Pleasingly, re-
placement of 8 by 3-methoxy-2-diethoxyphosphoryl-
acrylate (20)15 proved to be successful. When acrylate 20
and 1,2-diphenylhydrazine (21) were heated in refluxing
toluene for 80 hours the expected 4-diethoxyphosphoryl-
1,2-diphenyl-1,2-dihydro-3H-pyrazol-3-one (22) was ob-
tained in 83% yield (Scheme 3). In the next step we exam-
ined the addition of Grignard reagents to pyrazolone 22.
Unfortunately, all attempts to perform the addition of
methylmagnesium chloride to 22 under standard condi-
tions (0 °C to r.t., THF or Et2O as solvent, addition of CuI)
failed. However, performing this reaction in boiling THF
for two hours with 1.2 equivalents of MeMgCl gave, after
purification by column chromatography, the expected
5-methyl-4-diethoxyphosphoryl-1,2-diphenylpyrazolidin-
3-one (23a) in a reasonable 52% yield. Applying these op-
timized conditions we performed the reaction of several
Grignard reagents with pyrazolone 22 and obtained the
expected adducts 23b–e, usually as mixtures of trans and
cis isomers (Table 3).16 Contrary to pyrazolidinones 18, in
the 1H NMR spectra of 23 all signals were resolved and
JH4–H5 coupling constants could be easily determined. For
example, for the major and minor diastereoisomer of 23a
JH4–H5 coupling constants were 2.8 Hz and 6.7 Hz, respec-
tively, confirming the trans configuration of the latter if
pseudoaxial positions of phosphoryl and methyl groups
are assumed. To unequivocally confirm the trans config-
uration of the major isomer of pyrazolidinone 23a, a NOE
experiment was performed, showing 13% enhancement in
the signal of the H-4 proton when protons of the methyl
group in position 5 were irradiated. Because of similar
coupling constant patterns in all major isomers of pyr-
Table 2  Preparation of 1-Aryl-4-diethoxyphosphoryl-1H-pyrazol-5-ols 16a–g, 2-Aryl-4-diethoxyphosphoryl-1-methylpyrazol-3-ones 17a–g, 
2-Aryl-4-diethoxyphosphoryl-1-methypyrazolidin-3-ones 18a–g, and 2-Aryl-1-methyl-4-methylidenepyrazolidin-3-ones 19a–g
Entry Compd R Ar Yield of 16 
(%)a
Yield of 17 
(%)a
Yield of 18 
(%)a (trans/cis ratio)
Yield of 19 
(%)a
1 a Me Ph 86 61 75 (85:15) 72
2 b Et Ph 64 60 75 (90:10) 61
3 c i-Pr Ph 41 51 41 (65:35) 70
4 d n-Bu Ph 72 57 88 (90:10) 58
5 e Et 3-ClC6H4 72 75 70 (90:10) 79
6 f Ph Ph 75 65 84 (100:0) 63
7 g 4-MeOC6H4 Ph 72 61 51 (100:0) 85
a Yield of purified, isolated products based on 15, 16, 17, or 18, respectively.
Scheme 3  Reagents and conditions: (a) toluene, reflux, 80 h; (b) RMgX (1.2 equiv), THF, reflux, 2 h; (c) NaH (1.2 equiv), (CH2O)n (5 equiv),
THF, r.t., 2 h.
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azolidinones 23a–e, we construe that all major isomers
have the trans configuration. Phosphorylated pyrazoli-
dinones 23a–e were next used as Horner–Wadsworth–
Emmons reagents for the olefination with formaldehyde
to furnish the targeted 4-methylidene-1,2-diphenylpyr-
azolidin-3-ones 24a–e in excellent yields (Table 3).12
In summary, as a part of an ongoing program in our labo-
ratory focused on the application of Horner–Wadsworth–
Emmons approaches in the synthesis of biologically im-
portant 2-alkylidene-1-oxoheterocyles, we have devel-
oped a simple, effective, and general methodology for the
synthesis of novel 4-methylidenepyrazolidin-3-ones. As
disclosed, three complementary methods enable the intro-
duction of various alkyl or aryl substituents at positions 1,
2, and/or 5 on the pyrazolidinone ring and open access to
a new class of α-alkylidene-γ-lactams with potential cyto-
toxic activity. Further studies to extend the presented
methodology and to test the obtained compounds for their
cytotoxic activity are under way.
Acknowledgement
This work was financed by the Ministry of Science and Higher Edu-
cation (Project No. N N204 005736).
References and Notes
(1) Balczewski, P.; Mikolajczyk, M. Org. Lett. 2000, 2, 1153.
(2) (a) Kitson, R. R. A.; Millemaggi, A.; Taylor, R. J. K. Angew. 
Chem. Int. Ed. 2009, 48, 9426. (b) Albrecht, A.; Albrecht, 
Ł.; Janecki, T. Eur. J. Org. Chem. 2011, 2747.
(3) (a) Zhang, S.; Won, Y.-K.; Ong, C. N.; Shen, H. M. Curr. 
Med. Chem. – Anti-Cancer Agents 2005, 5, 239. (b) Zhang, 
S.; Ong, C. N.; Shen, H. M. Cancer Lett. 2004, 208, 143. 
(c) Heilmann, J.; Wasescha, M. R.; Smidt, T. J. Bioorg. Med. 
Chem. 2001, 9, 2189. (d) Knight, D. W. Nat. Prod. Rep. 
1995, 12, 271.
(4) Janecki, T. In Targets in Heterocyclic Systems: 
Organophosphorus Reagents as a Versatile Tool in the 
Synthesis of α-Alkylidene-γ-butyrolactones and α-
Alkylidene-γ-butyrolactams; Vol. 10; Attanasi, O. A.; 
Spinelli, D., Eds.; Italian Society of Chemistry: Rome, 2006, 
301.
(5) (a) Janecki, T.; Błaszczyk, E.; Studzian, K.; Janecka, A.; 
Krajewska, U.; Różalski, M. J. Med. Chem. 2005, 48, 3516. 
(b) Albrecht, A.; Koszuk, J. F.; Modranka, J.; Różalski, M.; 
Krajewska, U.; Janecka, A.; Studzian, K.; Janecki, T. 
Bioorg. Med. Chem. 2008, 16, 4872. (c) Albrecht, A.; 
Albrecht, Ł.; Różalski, M.; Krajewska, U.; Janecka, A.; 
Studzian, K.; Janecki, T. New J. Chem. 2010, 34, 750. 
(d) Modranka, J.; Albrecht, A.; Jakubowski, R.; Krawczyk, 
H.; Różalski, M.; Krajewska, U.; Janecka, A.; Wyrębska, A.; 
Różalska, B.; Janecki, T. Bioorg. Med. Chem. 2012, 20, 
5017.
(6) Janecki, T.; Wąsek, T.; Różalski, M.; Krajewska, U.; 
Studzian, K.; Janecka, A. Bioorg. Med. Chem. Lett. 2006, 
16, 1430.
(7) (a) Różalski, M.; Krajewska, U.; Panczyk, M.; Mirowski, 
M.; Różalska, B.; Wąsek, T.; Janecki, T. Eur. J. Med. Chem. 
2007, 248. (b) Wyrębska, A.; Gach, K.; Szemraj, J.; 
Szewczyk, K.; Hrabec, E.; Koszuk, J.; Janecki, T.; Janecka, 
A. Chem. Biol. Drug Des. 2012, 79, 112. (c) Wyrębska, A.; 
Szymański, J.; Gach, K.; Piekielna, J.; Koszuk, J.; Janecki, 
T.; Janecka, A. Mol. Biol. Rep. 2013, 40, 1655.
(8) (a) Belaud, C.; Roussakis, C.; Letourneux, Y.; Alami, N. E.; 
Villiéras, J. Synth. Commun. 1985, 15, 1233. (b) Elford, T. 
G.; Hall, D. G. Tetrahedron Lett. 2008, 49, 6995.
(9) Miller, P. C.; Molyneaux, J. M. Org. Prep. Proced. Int. 
1999, 31, 295.
(10) General Procedure for the N-Methylation: Synthesis of 
2-Aryl-4-diethoxyphosphoryl-1-methyl-1,2-dihydro-3H-
pyrazol-3-ones 12a–e and 2-Aryl-4-diethoxyphosphoryl-
1-methyl-1,2-dihydro-3H-pyrazol-3-ones 17a–g
A solution of the corresponding pyrazolol 11a–e (5 mmol) 
and (MeO)2SO2 (0.57 mL, 6 mmol) in DCE (50 mL) was 
heated at 80 °C for 18 h. The solvent was evaporated, and the 
crude product was purified by column chromatography 
(eluent: EtOAc–MeOH, 9:1). With the pyrazolols 16a–g the 
reaction was performed with CF3SO3Me (1.64 g, 10 mmol) 
at 80 °C for 2 h.
Diethyl [1-Methyl-3-oxo-2-(p-tolyl)-2,3-dihydro-1H-
pyrazol-4-yl]phosphonate (12c)
Pale-yellow oil. IR (film): 3035, 1655, 1509, 1258, 1029, 
758, 542 cm–1. 1H NMR (250 MHz, CDCl3): δ = 1.25 [t, 3JH–
H = 7.1 Hz, 6 H, (CH3CH2O)2P(O)], 2.28 (s, 3 H, CH3), 3.27 
(s, 3 H, CH3), 4.06–4.14 [m, 4 H, (CH3CH2O)2P(O)], 7.09 (d, 
3JH–H = 8.2 Hz, 2 H, 2 × HAr), 7.18 (d, 3JH–H = 8.2 Hz, 2 H, 
2 × HAr), 7.84 (d, 3JH–P = 4.4 Hz, 1 H, H-5). 13C NMR (62.9 
MHz, CDCl3): δ = 16.0 [d, 3JC–P = 6.9 Hz, (CH3CH2O)2P(O)], 
20.8 (s, CH3), 36.9 (s, CH3), 62.0 [d, 2JC–P = 5.6 Hz, 
(CH3CH2O)2P(O)], 93.8 (d, 1JC–P = 222.2 Hz, C-4), 126.3 (s, 
2 × CAr), 129.8 (s, 2 × CAr), 130.0 (s, CAr), 138.6 (s, CAr), 
147.1 (d, 2JC–P = 18.8 Hz, C5), 162.9 (d, 2JC–P = 14.0 Hz, 
C3). 31P NMR (101 MHz, CDCl3): δ = 12.51. Anal. Calcd 
for C15H21N2O4P: C, 55.55; H, 6.53. Found: C, 55.42; H, 
6.60. 
(11) General Procedure for L-Selectride Reduction: 
Synthesis of 2-Aryl-4-diethoxyphosphoryl-1-
methylpyrazolidin-3-ones 13a–e and 2-Aryl-4-
diethoxyphosphoryl-1-methylpyrazolidin-3-ones 18a–g
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Entry Compd  RMgX Yield of 23 
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Yield of 24 
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Diethyl [1-Methyl-3-oxo-2-(p-tolyl)pyrazolidin-4-
yl]phosphonate (13c)
Pale-yellow oil. IR (film): 2982, 1689, 1614, 1508, 1354 
1248, 1018, 963 cm–1. 1H NMR (250 MHz, DMSO-d6): δ = 1.24 [t, 3JH–H = 7.0 Hz, 3 H, (CH3CH2O)P(O)], 1.27 [t, 
3JH–H = 7.0 Hz, 3 H, (CH3CH2O)P(O)], 2.25 (s, 3 H, CH3), 
2.57 (s, 3 H, CH3), 3.56 (dd, 3JH–H = 9.2 Hz, 3JH–P = 14.5 Hz, 
2 H, 2 × H-5), 3.84 (dt, 3JH–H = 9.2 Hz, 2JH–P = 21.5 Hz, 1 H, 
H-4), 4.05–4.20 [m, 4 H, (CH3CH2O)2P(O)], 7.13–7.20 (m, 
2 H, 2 × HAr), 7.48–7.55 (m, 2 H, 2 × HAr). 13C NMR 
(62.9 MHz, DMSO-d6): δ = 15.5 [d, 3JC–P = 5.6 Hz, 
(CH3CH2O)2P(O)], 19.8 (s, CH3), 40.4 (d, 1JC–P = 146.9 Hz, 
C-4), 42.9 (s, CH3), 51.7 (d, 2JC–P = 1.8 Hz, C-5), 61.5 [d, 
2JC–P = 6.7 Hz, (CH3CH2O)P(O)], 61.9 [d, 2JC–P = 6.4 Hz, 
(CH3CH2O)P(O)], 119.7 (s, 2 × CAr), 128.7 (s, 2 × CAr), 
133.7 (s, CAr), 134.1 (s, CAr), 164.9 (d, 2JC–P = 2.3 Hz, C-
3). 31P NMR (101 MHz, DMSO-d6): δ = 23.13. Anal. Calcd 
for C15H23N2O4P: C, 55.21; H, 7.10. Found: C, 55.11; H, 
7.23.
(12) General Procedure for Methylidenation: Synthesis of 2-
Aryl-1-methyl-4-methylidenepyrazolidin-3-ones 14a–e, 
2-Aryl-1-methyl-4-methylidenepyrazolidin-3-ones 19a–
g, and 4-Methylidene-1,2-diphenylpyrazolidin-3-ones 
24a–e
To a solution of the corresponding pyrazolidinone 13a–e, 
18a–g, or 23a–e (0.5 mmol) in THF (5 mL), NaH (14 mg, 
0.6 mmol) was added, and the resulting mixture was stirred 
at r.t. for 30 min. Then, paraformaldehyde (75 mg, 2.5 
mmol) was added in one portion. After 2 h the reaction 
mixture was quenched with brine (5 mL), the solvent was 
evaporated, and the aqueous layer was extracted with 
CH2Cl2 (3 × 10 mL). The organic extracts were dried over 
MgSO4, filtered, and the solvent was evaporated. The crude 
product was purified by column chromatography (eluent: 
CH2Cl2).
1-Methyl-4-methylene-2-(p-tolyl)pyrazolidin-3-one (14c)
Pale-yellow oil. IR (film): 2960, 2858, 1693, 1662, 1492, 
1348, 822 cm–1. 1H NMR (250 MHz, CDCl3): δ = 2.32 (s, 3 
H, CH3), 2.56 (s, 3 H, CH3), 3.52–3.88 (m, 1 H, 1 × H-5), 
4.06–4.40 (m, 1 H, 1 × H-5), 5.49–5.51 (m, 1 H, HCH=), 
6.14–6.16 (m, 1 H, HCH=), 7.15–7.20 (m, 2 H, 2 × HAr), 
7.70–7.79 (m, 2 H, 2 × HAr). 13C NMR (62.9 MHz, CDCl3): δ = 19.5 (s, CH3), 45.9 (s, CH3), 55.8 (s, C-5), 117.9 (s, 
CH2=), 119.3 (s, 2 × CAr), 127.9 (s, 2 × CAr), 134.3 (s, 
CAr), 134.8 (s, CAr), 139.2 (s, C-4), 165.2 (s, C-3). Anal. 
Calcd for C12H14N2O: C, 71.26; H, 6.98. Found: C, 71.09; H, 
7.12. 
(13) Miller, P. C.; Curtis, J. M.; Molyneaux, J. M.; Owen, T. J. 
US 6,297,194 B1, 2001.
(14) General Procedure for the Synthesis of 1-Aryl-4-
diethoxyphosphoryl-1H-pyrazol-5-ols 16f,g
A mixture of ethyl 2-aroyl-2-diethoxyphosphorylacetate 
15f,g (10 mmol), phenylhydrazine (11 mmol), and AcOH 
(0.6 g, 20 mmol) was refluxed in H2O (50 mL) for 3 h. The 
reaction mixture was cooled and extracted with EtOAc 
(2 × 30 mL). The organic extracts were washed with brine, 
dried over Na2SO4, and concentrated. The crude product was 
purified by column chromatography (eluent: EtOAc–
hexane, 1:1). 
(15) Janecki, T.; Albrecht, A.; Koszuk, J. K.; Modranka, J.; 
Słowak, D. Tetrahedron Lett. 2010, 51, 2274.
(16) General Procedure for the Synthesis of 4-Diethoxy-
phosphoryl-1,2-diphenylpyrazolidin-3-ones 23a–e
To a solution of the 4-diethoxyphosphoryl-1,2-diphenyl-
pyrazol-3-one 22 (2 mmol) in THF (15 mL) a solution of the 
corresponding Grignard reagent (2.4 mmol) was added 
dropwise, under an argon atmosphere at r.t., and the resulting 
mixture was refluxed for 2 h. After this time the reaction 
mixture was quenched with H2O (5 mL), acidified to pH ca. 
3 with 10% aq HCl solution, and extracted with CH2Cl2 
(3 × 10 mL). The organic extracts were dried over MgSO4, 
filtered, and the solvent was evaporated. The crude product 
was purified by column chromatography (eluent: CHCl3–
MeOH, 98:2).
4-Diethoxyphosphoryl-1,2,5-triphenylpyrazolidin-3-one 
(23e)
Pale-yellow oil. IR (film): 2981, 1703, 1593, 1489, 1391, 
1250, 1014, 964 cm–1. 1H NMR (250 MHz, CDCl3): δ = 1.07 
[t, 3JH–H = 7.1 Hz, 3 H, (CH3CH2O)P(O)], 1.30 [t, 3JH–H = 7.0 
Hz, 3 H, (CH3CH2O)P(O)], 3.30 (dd, 2JH–P = 23.4 Hz, 3JH–
H = 3.0 Hz, 1 H, H-4), 3.67–3.84 [m, 1 H, (CH3CHO)P(O)], 
3.91–4.04 [m, 1 H, (CH3CHO)P(O)], 4.08–4.22 [m, 2 H, 
(CH3CH2O)P(O)], 5.39 (dd, 3JH–P = 19.1 Hz, 3JH–H = 3.0 Hz, 
1 H, H-5), 6.81–6.98 (m, 4 H, 4 × HAr), 7.10–7.24 (m, 3 H, 
3 × HAr), 7.31–7.43 (m, 4 H, 4 × HAr), 7.50–7.53 (m, 2 H, 
2 × HAr), 7.83–7.87 (m, 2 H, 2 × HAr). 13C NMR (62.9 
MHz, CDCl3): δ = 15.9 [d, 3JC–P = 5.4 Hz, (CH3CH2O)P(O)], 
16.1 [d, 3JC–P = 6.1 Hz, (CH3CH2O)P(O)], 46.7 (d, 1JC–
P = 137.2 Hz, C-4), 62.9 [d, 2JC–P = 6.9 Hz, (CH3CH2O)P(O)], 
63.3 [d, 2JC–P = 6.6 Hz, (CH3CH2O)P(O)], 68.6 (d, 2JC–
P = 0.9 Hz, C-5), 117.4 (s, 2 × CAr), 118.9 (s, 2 × CAr), 
123.1 (s, CAr), 125.0 (s, CAr), 125.2 (s, 2 × CAr), 128.1 (s, 
CAr), 128.7 (s, 2 × CAr), 128.9 (s, 2 × CAr), 129.1 (s, 
2 × CAr), 137.7 (s, CAr), 142.1 (d, 3JC–P = 12.1 Hz, CAr), 
149.4 (s, CAr), 164.6 (d, 2JC–P = 5.7 Hz, C-3). 31P NMR (101 
MHz, CDCl3): δ = 19.60. Anal. Calcd for C25H27N2O4P: C, 
66.66; H, 6.04. Found: 66.49; H, 5.97. 
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